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Drug addiction is a chronic, relapsing brain disorder which consists of compulsive patterns
of drug-seeking and taking that occurs at the expense of other activities. The transition
from casual to compulsive drug use and the enduring propensity to relapse is thought to be
underpinned by long-lasting neuroadaptations in specific brain circuitry, analogous to those
that underlie long-term memory formation. Research spanning the last two decades has
made great progress in identifying cellular and molecular mechanisms that contribute to
drug-induced changes in plasticity and behavior. Alterations in synaptic transmission within
the mesocorticolimbic and corticostriatal pathways, and changes in the transcriptional
potential of cells by epigenetic mechanisms are two important means by which drugs
of abuse can induce lasting changes in behavior. In this review we provide a summary of
more recent research that has furthered our understanding of drug-induced neuroplastic
changes both at the level of the synapse, and on a transcriptional level, and how these
changes may relate to the human disease of addiction.
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INTRODUCTION
Drug addiction is a chronic, relapsing disorder characterized by
uncontrolled, compulsive drug use that persists despite serious
negative consequences. One of the most insidious features of
addiction is the enduring susceptibility to relapse displayed by
users despite months or even years of abstinence (O’Brien, 1997).
Importantly, not everyone who uses drugs becomes addicted,
and whether or not a person makes this transition can be influ-
enced by a complex interplay of genetic and environmental factors
(Goldman et al., 2005; Kendler et al., 2007). The escalation of drug
use from casual to compulsive and the persistent vulnerability to
relapse is thought to be underpinned by long-lasting neuroad-
aptations in brain reward circuits (Thomas et al., 2008; Luscher
and Malenka, 2011; Robison and Nestler, 2011). Essentially all
drugs of abuse exert their acute reinforcing properties via the
mesocorticolimbic dopamine pathway, encompassing dopamine
neurons that originate in the ventral tegmental area (VTA) and
project to the striatum and other limbic regions including the
prefrontal cortex (PFC), amygdala and hippocampus (Di Chiara
and Imperato, 1988; Le Moal and Simon, 1991). The striatum also
receives glutamatergic input from the PFC, and while mesolimbic
dopamine is no doubt important for the initial stages of drug-
taking and reinforcement, a role for corticostriatal glutamate
transmission in the compulsive and enduring nature of addic-
tion is being increasingly recognized (Kalivas, 2009; Kalivas et al.,
2009). A major focus of research at present lies in characterizing
the cellular and molecular changes that occur within this moti-
vational circuitry to contribute to the development and persis-
tence of addiction. In the laboratory, various behavioral facets
of addiction can be investigated using animal models (summa-
rized in Table 1). The purpose of this review is to provide an
overview of the neuroplastic changes that occur both at the
synapse, and on the level of gene transcription, that contribute
to addiction-related behaviors.
SYNAPTIC PLASTICITY MECHANISMS: ADDICTION AS A
PATHOLOGICAL FORM OF LEARNING ANDMEMORY
The observation that drug-taking and relapse are quite often
directly linked to exposure to drug-related cues highlights the
importance of associative learning mechanisms in addiction
(Wikler and Pescor, 1967; Tiffany and Drobes, 1990; O’Brien
et al., 1998). Steven Hyman made the point that “memory dis-
orders are often thought of as conditions involving memory loss,
but what if the brain remembers too much or too powerfully
records pathological associations?” (Hyman, 2005). In this con-
text, addiction can be perceived, at least in part, as a pathological
form of learning and memory. In support of this hypothesis
research over the last decade has demonstrated that drugs of abuse
do indeed modify synaptic plasticity in the mesocorticolimbic
and corticostriatal circuitry by similar mechanisms that underlie
long-term memory formation. What these modifications actually
represent in terms of behavior and addiction more generally is
another, perhaps more challenging, question. The following sec-
tion will overview the synaptic adaptations caused by drugs of
abuse as measured electrophysiologically in the context of animal
models and their relevance to the addicted state.
It was Santiago Ramon y Cajal who, over 100 years ago,
contemplated the idea that changes in the strength of synaptic
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Table 1 | Modeling addiction in animals.
Locomotor sensitization: Locomotor sensitization describes the progressive increase in locomotor activity that usually follows repeated, intermittent
drug exposure. Sensitization can persist for months or even years following withdrawal, and as such it is considered to be an indication of enduring
drug-induced plasticity (Steketee, 2003). Although it is most commonly studied in relation to psychostimulants, sensitization has also been characterized
in response to opiates, nicotine and ethanol (Shuster et al., 1977; Kalivas and Duffy, 1987; Robinson et al., 1988; Benwell and Balfour, 1992;
Cunningham and Noble, 1992). Cross-sensitization between different drugs of abuse has also been shown to exist, suggesting that common
mechanisms underlie the development of this phenomenon despite these drugs having distinct pharmacological actions in the brain (Vezina and
Stewart, 1990; Itzhak and Martin, 1999; Beyer et al., 2001; Cadoni et al., 2001).
Conditioned place preference (CPP): CPP is an indirect measure of drug reward based on classical (Pavlovian) conditioning principles (Tzschentke,
1998). The CPP apparatus consists of two distinct environments, one of which is paired with a drug, and with repeated pairing the drug-paired
environment acquires secondary motivational properties which can elicit approach behavior. An animal is said to have obtained a place preference if it
spends more time in the drug-paired environment when given a choice. This paradigm is used to measure conditioned drug reward and associative
learning.
Operant self-administration: Animals can be trained to self-administer most drugs that are commonly abused by humans. This is usually achieved
using operant boxes where an instrumental task such as a lever press or nose poke results in the delivery of a drug or natural reward. Reward delivery
can be paired with a discrete cue such as a tone or light, or passive contextual cues.
Extinction/reinstatement: Extinction describes a reduction in conditioned drug-seeking behavior after it is repeatedly non-reinforced (Myers and Davis,
2002). Extinction can be performed in the context of CPP, where an animal is repeatedly exposed to the drug-paired environment in the absence of the
drug. Once a CPP is extinguished, it can be reinstated by drug priming (Mueller and Stewart, 2000) or exposure to stressors (Sanchez and Sorg, 2001;
Wang et al., 2006). Operant self-administration behavior can also be extinguished by removal of drug reinforcement, and subsequently reinstated by
non-contingent exposure to the drug (Dewit and Stewart, 1981), exposure to cues or contexts previously associated with the drug (Meil and See, 1996;
Weiss et al., 2000; Crombag and Shaham, 2002), or exposure to stress (Shaham and Stewart, 1995; Erb et al., 1996; Shepard et al., 2004). These same
factors are known to precipitate drug craving and relapse in human addicts, and as such reinstatement attempts to model relapse-like behavior in
animals.
connections between neurons could be the way in which the
brain stores information (Cajal, 1894). The discovery of long-
term potentiation (LTP) in the hippocampus in 1973 provided
the first evidence that this may be the case (Bliss and Lomo,
1973). LTP is the enhancement of synaptic strength that results
from synchronous firing of connecting neurons, whereas its coun-
terpart long-term depression (LTD) is the weakening of synap-
tic strength (Citri and Malenka, 2008). These processes usually
involve N-methyl-D-aspartate (NMDA) receptor-mediated traf-
ficking of α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate
(AMPA) receptors to and from the cell surface (Kauer and
Malenka, 2007). An NMDA receptor-mediated increase in cal-
cium levels in the postsynaptic cell is required for the induction
of LTP and LTD, with the amount of calcium determining the
sequence of events. Large increases in calcium preferentially acti-
vate protein kinases and result in LTP, ultimately expressed as
enhanced transmission at postsynaptic AMPA receptors. In con-
trast, more modest increases in calcium preferentially activate
protein phosphatases and produce LTD, which is expressed as a
decrease in AMPA receptor transmission (Kauer and Malenka,
2007). While LTP and LTD were initially studied in relation
to learning and memory in the hippocampus, they are now
known to occur at most excitatory synapses throughout the
central nervous system, and are important for many forms of
experience-dependent plasticity (Malenka and Bear, 2004; Kauer
and Malenka, 2007).
DRUG-EVOKED POTENTIATION AT EXCITATORY SYNAPSES IN THE VTA
A pioneering study by Ungless and colleagues in 2001 demon-
strated that a single exposure to cocaine caused an enhancement
of synaptic strength at excitatory synapses on VTA DA neurons
when measured 24 h later in brain slices (Ungless et al., 2001).
This was measured as an increase in the ratio of AMPA-mediated
excitatory postsynaptic currents (EPSCs) over NMDA-mediated
EPSCs (termed the AMPA/NMDA ratio). Subsequent electrically-
evoked LTP was shown to be occluded at excitatory VTA synapses
in cocaine-treated mice whereas LTD was enhanced. These obser-
vations as well as a number of other electrophysiological measures
indicated that the change in plasticity observed potentially shared
similar mechanisms to synaptically-evoked LTP (Ungless et al.,
2001). It has since been shown that administration of other
drugs of abuse including amphetamine, morphine, ethanol, nico-
tine, and benzodiazepines can also induce increases in synaptic
strength in the VTA, an effect that is not seen with psychoac-
tive drugs that do not have abuse potential (Saal et al., 2003;
Gao et al., 2010; Tan et al., 2010). This observation demon-
strates a convergence of cellular responses within the VTA by
all abused drugs and provides a possible neural mechanism by
which initial neuroadaptations underlying addiction could be
triggered.
The effect of non-contingent drug administration on VTA
synaptic plasticity is transiently expressed, lasting at least 5 but
less than 10 days and has been shown to positively correlate with
the initial development of behavioral sensitization but not with
its expression (Ungless et al., 2001; Saal et al., 2003; Borgland
et al., 2004). If cocaine is self-administered the outcome is rather
different as plasticity in the VTA becomes persistent and can
be detected even 90 days into withdrawal (Chen et al., 2008).
The potentiation of glutamatergic synapses on VTA DA cells is
presumably linked to the ability of drugs of abuse to enhance
extracellular DA in the NAc (Di Chiara and Imperato, 1988)
and potentially represents the initiation of “pathological” reward
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learningwhereby a “stamping in” of drug-cue associations occurs.
Indeed, NMDA receptor-dependent increases in glutamatergic
synaptic strength have been reported in VTA DA neurons during
the acquisition of a cue-reward association (Stuber et al., 2008)
and recently it was confirmed that cocaine selectively increases
the AMPA/NMDA ratio of VTA neurons which project to the
NAc as opposed to the PFC (Lammel et al., 2011); it is well estab-
lished that dopamine transmission within the NAc is critical for
the acquisition of a Pavlovian association (Kelley, 2004). Thus it
may be that that potentiation of VTA DA neurons may represent
neural coding similar to LTP, possibly an associative learning pro-
cess, which may be essential for early cocaine-induced behavioral
responses and has the capacity to trigger long-term adaptations
that underlie addiction, though does not represent the addicted
state itself. As proposed by others, it may be that addictive drugs
co-opt brain reward circuitry to “overlearn” the value of a drug to
the organism (Kauer and Malenka, 2007).
The origins of the pertinent glutamatergic projections to the
VTA involved in drug-induced plasticity remain to be fully elu-
cidated. One study has revealed that VTA glutamatergic synapses
targeted by projections from both the VTA itself and the pedun-
culopontine nucleus (PPN) show enhanced potentiation from
cocaine yet only the synapses receiving input from PPN affer-
ents are potentiated with9-tetrahydrocannabinol (THC) (Good
and Lupica, 2010). Thus, it appears that the particular gluta-
matergic afferents involved in drug-induced potentiation can vary
according to the drug in question and it may also be the case
that a particular projection is common to all drug-evoked exci-
tatory plasticity in the VTA; the latter is yet to be determined. The
VTA receives extensive projections from multiple brain regions
including the PFC, amygdala and subthalamic nucleus (Geisler
and Wise, 2008), many of which have been shown to influence
the burst firing of VTA DA neurons (Grillner andMercuri, 2002).
Future experiments utilizing optogenetic techniques could assist
in determining the particular projections responsible the drug-
evoked potentiation at VTA synapses observed in response to
various drugs of abuse, thus shedding light on the on the exact
nature of this neuroadaptation.
MECHANISMS UNDERLYING DRUG-EVOKED SYNAPTIC
PLASTICITY AT EXCITATORY SYNAPSE IN THE VTA
As with electrically-induced LTP in midbrain DA neurons the
increase in synaptic strength in the VTA induced by both cocaine
and nicotine has been shown to be dependent on NMDA recep-
tor activation (Bonci and Malenka, 1999; Ungless et al., 2001;
Mao et al., 2011). In contrast, the maintenance of cocaine-evoked
potentiation was recently shown to require the activity of protein
kinase Mζ (Ho et al., 2012), an autonomously active protein
kinase C (PKC) isoform, whereas spike timing-dependent LTP
in VTA DA neurons of drug-naïve mice depends on conven-
tional PKC isoforms (Luu and Malenka, 2008). In the case of
nicotine the VTA synaptic potentiation requires the excitation of
DA neurons mediated by somatodendritic α4β2 nicotinic acetyl-
choline receptors (nAChRs) (Mao et al., 2011). Nicotine-induced
increases of presynaptic glutamate release also contribute to the
induction of this particular synaptic plasticity, likely through
increased activation of NMDA receptors (Mao et al., 2011).
Relatively more is known about the mechanisms underlying
cocaine-evoked synaptic plasticity than that underlying plastic-
ity induced by other drugs of abuse. Cocaine application to
midbrain slices results in potentiation of NMDA receptor trans-
mission within minutes and is proposed to be via insertion of
NR2B-containing NMDARs into synapses through a mechanism
that requires activation of D5 receptors and new protein syn-
thesis (Schilstrom et al., 2006; Argilli et al., 2008). Orexin A
has also been shown to be required for both rapid cocaine-
induced insertion of NR2B-containing receptors and increased
AMPA/NMDA ratios; accordingly the orexin1 receptor antago-
nist SB334867 has been shown to prevent the development of
sensitization to cocaine (Borgland et al., 2006). In addition to
changes in NMDA receptor subunit expression, increased lev-
els of GluR1-containing (GluR2-lacking) AMPA receptors at
synapses have been observed as soon as 3 h after cocaine expo-
sure (Argilli et al., 2008). This observation combined with other
recent evidence has led to the hypothesis that synaptic inser-
tion of high-conducting GluR2-lacking receptors contribute to
expression of cocaine-induced synaptic potentiation in the VTA
(Dong et al., 2004; Bellone and Luscher, 2006; Mameli et al.,
2007; Brown et al., 2010; Mameli et al., 2011), for reviews see
(Kauer and Malenka, 2007; Wolf and Tseng, 2012). This insertion
of GluR2-lacking AMPA receptors depends on NMDA receptor
transmission in VTA DA neurons since it is absent in mice lack-
ing functional NMDA receptors in DA neurons (Engblom et al.,
2008; Mameli et al., 2009). Insertion of GluR2-lacking AMPA
receptors is significant because they have unique properties;
they are calcium permeable, have greater single channel con-
ductance than GluR2-containing receptors, and therefore have a
huge capacity to alter synaptic transmission (Isaac et al., 2007).
Hence, insertion of GluR2-lacking AMPA receptors in the VTA
represents a possible mechanism by which drugs of abuse can
instantiate the plastic adaptations underlying the initial stages of
drug use.
The insertion of GluR2-lacking AMPA receptors into VTA
excitatory synapses has now been shown to occur in response
to administration of drugs from multiple classes such as nico-
tine and morphine as well as upon optogenetic activation of
DA VTA neurons (Brown et al., 2010). This has led to the pro-
posal that insertion of calcium-permeable GluR2-lacking AMPA
receptors represents a universal mechanism which may under-
lie drug-evoked potentiation of VTA synapses (Brown et al.,
2010), though the data for amphetamine are not necessarily
consistent with this hypothesis (Faleiro et al., 2004). Moreover,
as GluR2-lacking AMPA receptors are inwardly rectifying and
thus conduct very little current at +40mV, their insertion alone
cannot explain drug-evoked increases in AMPA/NMDA ratios.
A recent study whichmeasured unitary synaptic responses evoked
by a highly localized glutamate source (two-photon photolysis of
caged glutamate) showed, than in addition to affecting AMPA
receptor-mediated EPSCs, cocaine exposure also decreased uni-
tary NMDA receptor-mediated EPSCs (Mameli et al., 2011), thus
providing a possible mechanism by which AMPA/NMDA ratios
could be increased in this scenario (by lowering the denomina-
tor of the ratio). This is yet to be investigated with other drugs
of abuse.
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The drug-induced exchange of GluR2-containing with GluR2-
lacking AMPA receptors can be reversed by activation of mGluR1
receptors in the VTA (Bellone and Luscher, 2006; Mameli et al.,
2007). Thus, mGluR1-mediated exchange of AMPA receptors
provides a mechanism which can explain why drug-evoked
potentiation of VTA synapses is transient in nature, lasting 5 but
not 10 days (Ungless et al., 2001; Mameli et al., 2007). Indeed,
if mGluR1 function in the VTA is reduced 24 h before cocaine
administration then cocaine-induced inward rectification persists
beyond 7 days (Mameli et al., 2007, 2009). Hence one possible
explanation for why cocaine-evoked synaptic strengthening per-
sists in the VTA following self-administration of cocaine (unlike
following non-contingent administration) could be that cocaine
self-administration leads to depression of mGluR1 signaling in
the VTA.
DRUG–EVOKED SYNAPTIC PLASTICITY AT INHIBITORY SYNAPSES
IN THE VTA
Excitatory synapses are not the only type of synapse in VTA
DA neurons which are affected by non-contingent administra-
tion of drugs of abuse. Inhibitory synapses in the VTA also
have a critical role in controlling the firing rate of DA neurons,
thus plasticity at GABAergic synapses has the capacity to dra-
matically influence DA transmission. Indeed, cocaine, morphine
and ethanol can all influence inhibitory synaptic plasticity in the
VTA (Melis et al., 2002; Liu et al., 2005; Nugent et al., 2007).
Repeated cocaine exposure in vivo for 5–7 days causes a reduc-
tion in amplitudes of GABA-mediated synaptic currents, thereby
facilitating LTP induction in VTA cells by reducing the strength
of GABAergic inhibition (Liu et al., 2005). Subsequent studies
reveal the mechanism of this inhibition to be endocannabinoid-
dependent LTD at GABAergic synapses involving activation of
ERK1/2 (Pan et al., 2008, 2011). GABAA receptor synapses on
VTA dopamine neurons also exhibit robust NMDA-dependent
LTP (termed LTPGABA) in response to high-frequency stimula-
tion (Nugent et al., 2007). This LTPGABA is absent in VTA slices
2 and/or 24 h after in vivo administration of morphine, nico-
tine, cocaine or ethanol (Nugent et al., 2007; Guan and Ye, 2010;
Niehaus et al., 2010). In the case of ethanol the prevention of
LTPGABA is mediated by the μ-opioid receptor (Guan and Ye,
2010) Together with synaptic potentiation at excitatory synapses,
this loss of LTPGABA should increase the firing of VTADA neurons
following drug exposure.
Slow GABA transmission has also recently been shown to
be affected by drugs of abuse. Thus a single dose of metham-
phetamine or cocaine is sufficient to significantly weaken the
ability of GABAB receptors to control VTA GABA neuron fir-
ing when measured ex vivo 24 h later (Padgett et al., 2012).
The methamphetamine-induced loss of the slow inhibitory post-
synaptic potential (IPSC) arises from a reduction in GABAB
receptor-G protein-coupled inwardly-rectifying potassium chan-
nel (GIRK) currents, due to changes in protein trafficking, and is
accompanied by a significant decrease in the sensitivity of presy-
naptic GABAB receptors in GABA neurons of the VTA. Unlike
drug-induced influences on GABAA synapses this depression of
GABABR-GIRK signaling persists for days after the injection
(Padgett et al., 2012).
BEHAVIOURAL CORRELATES OF DRUG-EVOKED POTENTIATION
IN VTA DA CELLS
As mentioned earlier the effect of non-contingent drug admin-
istration on synaptic plasticity in VTA DA neurons is tran-
siently expressed, lasting at least 5 but less than 10 days and
has been shown to positively correlate with the initial devel-
opment of behavioral sensitization but not with its expression
(Ungless et al., 2001; Saal et al., 2003; Borgland et al., 2004).
In support of the hypothesis that drug-evoked potentiation of
VTA synapses represents induction of behavioral sensitization,
intra-VTA administration of glutamate antagonists reduce, and
virally-mediated GluR1 up-regulation enhances the locomotor
sensitizing properties of drugs (Carlezon et al., 1997; Carlezon
and Nestler, 2002). Strong evidence of NR2A- and B-containing
NMDA receptor involvement is provided by the observation that
pharmacological inhibition of either prevents both the develop-
ment of sensitization and associated cocaine-induced increases
in AMPA/NMDA ratios (Schumann et al., 2009). However, mice
with targeted deletion of NR1 or GluR1 (selective to midbrain
DA neurons) or global GluR1 deletion exhibit intact behav-
ioral sensitization and yet show impaired AMPA receptor cur-
rents after cocaine treatment (Dong et al., 2004; Engblom et al.,
2008). An added twist is provided by the observation that CPP
and conditioned locomotor behavior is absent in GluR1 knock-
out mice (Dong et al., 2004) and extinction of cocaine CPP
is absent in mice with GluR1 deletion targeted to midbrain
DA neurons (Engblom et al., 2008), whereas in NR1 knockout
mice reinstatement of cocaine CPP and expression of behav-
ioral sensitization is attenuated (Engblom et al., 2008; Zweifel
et al., 2008). Thus, even with the caveat of potential develop-
mental compensation in mutant mice and/or possible incom-
plete deletion, it is possible that that neural processes governing
drug-evoked potentiation of DA neurons and behavioral sensiti-
zation are dissociated. Rather it may be that potentiation of VTA
synapses may contribute to the attribution of incentive salience to
drug-associated cues.
Measuring synaptic changes following non-contingent drug
administration is limited with respect to informing on the actual
disease state of addiction. More relevant to the human condi-
tion are studies where changes in synaptic plasticity are mea-
sured following contingent drug administration e.g., operant
self-administration. In this regard, synaptic strengthening of VTA
DA cells induced by self-administration of cocaine is uniquely
persistent, lasting 3 months into abstinence and shown to be
resistant to extinction training (Chen et al., 2008). Thus, though
initially proposed to be a transient event, it appears that drug-
evoked plasticity in the VTA has the capacity to be long-lasting,
demonstrating that the method of administration (contingent
versus non-contingent) is a critical determinant of its longevity.
This is supported by the observation that yoked controls in
this study did not show a similar increase in AMPA/NMDA
ratio; suggesting it is the learning of the cue-reward or action-
outcome association which is driving plasticity. In contrast,
self-administration of food or sucrose under similar parame-
ters produce increases in AMPA/NMDA ratios that persist for
7 but not 21 days into abstinence, demonstrably transient com-
pared to that induced by cocaine (Chen et al., 2008). The lack
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of persistence of food-induced plasticity demonstrates that the
change in synaptic strength induced by cocaine is not merely a
neural representation of the instrumental or cue-reward learning
processes involved in the operant self-administration paradigm
per se, rather a drug-specific effect which potentially represents
a pathological strengthening of drug-cue associations. As men-
tioned previously, cues predicting reward have also been found to
cause an increase in AMPA/NMDA ratios in the VTA, though not
as persistent, supporting a role for this modification of excitatory
synaptic function in reward learning (Stuber et al., 2008).
Interestingly, the magnitude of the increase in the
AMPA/NMDA ratio is similar regardless of the number of
injections (single vs. multiple), administration protocol (contin-
gent vs. non-contingent), and length of access (limited access vs.
extended access) (Borgland et al., 2004; Chen et al., 2008; Mameli
et al., 2009). This indicates that the increase in AMPA/NMDA
ratio observed in VTA DA cells is potentially a permissive event,
perhaps signaling “salience” as opposed to representing an ini-
tiation of underlying neuropathology which would presumably
increase with continued exposure.
DRUG-EVOKED PLASTICITY AT EXCITATORY SYNAPSES IN THE NAc
Unlike the VTA a single cocaine injection does not cause increases
in synaptic strength in the NAc when measured 24 h later
(Thomas et al., 2001; Kourrich et al., 2007). This observation and
the bidirectional timescale which follows with repeated adminis-
tration and withdrawal demonstrates that drug-induced plasticity
in the NAc is markedly different from that observed in the
VTA. Indeed, when repeated injections of cocaine are admin-
istered (so as to induce behavioral sensitization), a decrease in
the AMPA/NMDA ratio is observed at NAc shell synapses when
measured 24 h after the last administration (Kourrich et al.,
2007). This synaptic depression from repeated cocaine appears
to be linked to plasticity in the VTA; upon selective disrup-
tion of mGluR1 function in the VTA only a single injection of
cocaine is then required to cause this same depression of NAc
synapses (Mameli et al., 2009). The authors of this study pos-
tulate that enhanced excitation of VTA projections may facilitate
the coincident release of DA and glutamate in the NAc through
an enhanced release of DA. This may then shift the threshold
for the induction of local plasticity in the NAc by affecting cir-
cuit excitability or by integrating intracellular signaling processes
(Mameli et al., 2009).
The functional significance of the depression of NAc synapses
during acute withdrawal is unclear at this stage. One possi-
ble explanation may be that depression of NAc medium spiny
neurons (MSNs) reduces their response to natural rewarding
stimuli, hence contributing to the anhedonia experienced dur-
ing acute withdrawal. It could also be that the decrease observed
in the AMPA/NMDA ratio may be result of membrane inser-
tion of NR2B-containing NMDA receptors (thus increasing the
denominator of the ratio) as new silent synapses are found to
occur in the NAc shell upon cocaine exposure (Huang et al.,
2009). Silent glutamatergic synapses, which express functional
NMDA receptor-mediated currents in the absence of AMPA
receptor-mediated currents, are thought to possess an increased
capacity to undergo strengthening of synaptic transmission (Isaac
et al., 1995). Once generated, these silent synapses may facil-
itate recruitment of AMPA receptors thereby enhancing exci-
tatory synaptic transmission. This provides a possible mecha-
nism to explain increases in the surface level of AMPA recep-
tors and subsequent AMPAR/NMDAR ratio observed in the
NAc during protracted withdrawal (Boudreau and Wolf, 2005;
Boudreau et al., 2007; Kourrich et al., 2007; Conrad et al.,
2008). NR2B-containing NMDA receptors in the NAc could
also been involved in the formation of drug-context associ-
ations as siRNA knockdown of this subunit prevents mor-
phine CPP in mice but not behavioral sensitization (Kao et al.,
2011).
Unlike cocaine, a repeated regimen of intermittent ethanol
exposure results in a potentiation of synapses in response to a
previously LTD-inducing stimulation protocol when measured
24 h after the last exposure (Jeanes et al., 2011). This NMDA-
dependent potentiation is transient as after a further 48 h of with-
drawal it has dissipated and neither LTP nor LTD can be induced
(Jeanes et al., 2011). The authors interpret such robust changes
in NAc plasticity as an indicator of the potential importance
of this process in ethanol-induced neuroadaptations. Moreover,
unlike psychostimulants, ethanol can act at NMDA receptors
so therefore has the capacity to directly influence glutamatergic
signaling.
SYNAPTIC POTENTIATION OBSERVED IN THE NAc AFTER
A PERIOD OF WITHDRAWAL
In contrast to the depression observed during acute withdrawal,
potentiation of NAc shell synapses is observed after 10–14 days
of withdrawal from repeated cocaine or morphine administra-
tion (Kourrich et al., 2007; Wu et al., 2012). Moreover, after
7 days withdrawal from a single administration of cocaine, an
increase in the amplitude of mEPSCs as well as a loss of LTP
induced by high frequency stimulation (HFS) is found in both
core and shell NAc neurons expressing the dopamine D1 receptor
(Pascoli et al., 2012). This change in the ability to induce synaptic
plasticity is referred to as metaplasticity. Cocaine-induced meta-
plasticity is also observed following withdrawal from cocaine self-
administration. Thus, rats that have self-administered cocaine
followed by 3 weeks of either extinction or abstinence display a
marked in vivo deficit in the ability to develop LTP in the NAc core
after stimulation of the PFC. This observation was accompanied
by a leftward shift in the input-output curve suggesting potentia-
tion of fEPSP amplitude (Moussawi et al., 2009). Potentiation of
NAc synapses is also observed in the form of increased AMPA-
mediated currents following an extended period of abstinence
after self-administration (Conrad et al., 2008). Collectively, these
data suggest that synaptic potentiation in the NAc develops either
as a function of duration of withdrawal, or as a function of
time since the first administration of cocaine. A recent study
supports the latter interpretation as similar increases in the fre-
quency of mEPSCs was observed in D1 receptor-expressing MSNs
in mice despite the absence or presence of a protracted with-
drawal period following repeated cocaine administration (Dobi
et al., 2011). Therefore, it seems the events leading to the changes
in glutamatergic transmission in the NAc take some time to
develop.
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The contribution of specific AMPA receptor subunits to this
change varies according to the stage of withdrawal and the
method of administration; 10–21 days into withdrawal from both
passive and self-administration GluR2-containing AMPA recep-
tors appear to be responsible for changes in AMPA transmission
(Boudreau andWolf, 2005; Boudreau et al., 2007; Kourrich et al.,
2007; Ferrario et al., 2010) whereas beyond 21 days GluR2-
lacking AMPA receptors are added to synapses. The latter finding
appears to be the case only when cocaine is self-administered
(Conrad et al., 2008; McCutcheon et al., 2011), though see
(Mameli et al., 2009). Given the increased conductance of GluR2-
lacking AMPA receptors it may be that their insertion occurs in
response to the depression of NAc synapses caused by cocaine
self-administration, thereby resulting in increased MSN respon-
siveness to excitatory inputs that trigger cocaine-seeking in the
future. Indeed, blocking GluR2-lacking AMPA receptors in the
NAc prevents expression of incubated cue-induced cocaine seek-
ing (Conrad et al., 2008), and cocaine-seeking induced by either
AMPA or cocaine is also blocked by injections of antisense
oligonucleotides of GluR1mRNA into the NAc (Ping et al., 2008).
DRUG CHALLENGE AFTERWITHDRAWAL REVERTS SYNAPTIC
POTENTIATION TO DEPRESSION
The increase in synaptic strength and surface expression of AMPA
receptor subunits induced by cocaine in the NAc after withdrawal
from non-contingent administration is subsequently reversed
upon administration of further cocaine injections (re-challenge)
(Thomas et al., 2001; Boudreau et al., 2007; Kourrich et al., 2007;
Ferrario et al., 2010). Thus, synaptic depression is once again
observed in the NAc shell when measured 24 h after this cocaine
injection (Thomas et al., 2001), though see (Pascoli et al., 2012).
Behaviorally this appears to correlate with the expression of sensi-
tization, and in the case of amphetamine at least, has been shown
to be clathrin-mediated and reliant on GluR2-dependent endo-
cytosis of postsynaptic AMPA receptors (Brebner et al., 2005).
The decrease in surface expression of AMPA receptors following
cocaine challenge is transient as within 7 days surface expression
recovers to levels comparable to unchallenged cocaine-pretreated
rats (Ferrario et al., 2010). As such, it appears that history of
cocaine exposure and withdrawal can readily change the direction
of synaptic plasticity in the NAc.
A direct link was recently made between the potentiation of
cortico-accumbal synapses on D1 receptor-positive cells following
7 days withdrawal and the expression of sensitization. As men-
tioned previously, after 7 days withdrawal from a single adminis-
tration of cocaine, these synapses are found to be potentiated in
both the core and shell (as measured by an increase in mEPSC
amplitude) and LTP induced by HFS is reduced. The same was
not found for synapses on D2 receptor-positive cells (Pascoli
et al., 2012). When reversed optogenetically in vivo via a protocol
known to induce LTD, cortico-accumbal synapses on D1-receptor
positive cells displayed reduced mEPSCs and the expression of
locomotor sensitization was prevented. Importantly, the ability
of HFS to induce LTP was restored to these neurons (Pascoli
et al., 2012), thus demonstrating a direct link between this par-
ticular synaptic adaptation at cortico-accumbal synapses and the
expression of sensitization to cocaine.
PERSISTENT IMPAIRMENTS IN NAc CORE PLASTICITY UNDERLIE THE
TRANSITION TO ADDICTION
As mentioned above, it appears that cocaine induces metaplastic
changes in NAc MSNs. The term “metaplasticity” was originally
coined by Abraham and Bear to describe the change in the abil-
ity of synapses to undergo future plasticity (Abraham and Bear,
1996). Thus, a loss of LTD is observed in both the NAc core and
shell 24 h following the end of cocaine self-administration; how-
ever after 21 days abstinence this deficit is found exclusively in the
core (Martin et al., 2006). The same deficit is not found in yoked
animals nor animals that have self-administered food, demon-
strating it to be specific to the voluntary self-administration
of cocaine and not associated with instrumental learning nor
the cocaine exposure per se (Martin et al., 2006), thus raising
the possibility that drug-induced metaplasticity in the NAc core
may underlie the transition from casual use to compulsive drug-
seeking behavior. The impairment in NAc synapses induced by
cocaine self-administration may manifest in drug addicts as an
inability to inhibit their behavior and thus prevent compulsive
drug-intake.
Subsequent in vivo electrophysiological experiments support
this hypothesis. Self-administered cocaine followed by extinc-
tion training was shown to induce metaplasticity which impaired
the ability of PFC stimulation to produce LTP or LTD in NAc
core MSNs (Moussawi et al., 2009). Moreover, administration of
N-acetylcysteine, a drug which normalizes glutamate levels and
reduces craving in addicts (Amen et al., 2011), was found to
reverse this cocaine-induced metaplasticity and restore the abil-
ity to induce LTP or LTD (Moussawi et al., 2009). These findings
have been extended to an animal model of relapse, the reinstate-
ment model (see Table 1). Treatment with N-acetylcysteine was
shown to attenuate reinstatement of drug-seeking induced by
either cue or prime, an effect that persisted 2 weeks beyond cessa-
tion of treatment. Importantly, this attenuation was linked to its
ability to restore synaptic strength to cortico-accumbal synapses
(Moussawi et al., 2011).
These data provide a possible causal relationship between
cocaine-induced plasticity at cortico-accumbal synapses and sus-
ceptibility to relapse, consistent with a glutamate homeosta-
sis theory of addiction. Thus, a failure of the PFC to control
drug-seeking behaviors can be linked to an enduring imbal-
ance between synaptic and non-synaptic glutamate (Kalivas,
2009). Chronic cocaine results in reduced basal levels of gluta-
mate due to down-regulation of the cystine-glutamate exchanger.
This removes tone from presynaptic mGlu2/3 receptors located
at cortico-striatal synapses which normally function to limit
glutamate release (Kalivas, 2009). N-acetylcysteine inhibits
drug-seeking by activating the cystine-glutamate exchanger,
thereby increasing extrasynaptic glutamate and stimulating presy-
naptic mGluR2/3 receptors to reduce the glutamate release
associated with drug-seeking (Kalivas, 2009). Given the strong
link between mGluR2/3 regulation of both synaptic glutamate
release and drug-seeking, the capacity of mGluR2/3 antago-
nist to inhibit N-acetylcysteine restoration of LTP is consistent
with the possibility that normalizing cortico-accumbal plas-
ticity is ameliorative in terms of relapse (Moussawi et al.,
2009).
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Further evidence supporting a key role for adaptations at
NAc glutamatergic synapses in drug-seeking behavior is pro-
vided by observations that up-regulation of GluR2-lacking AMPA
receptors mediate the incubation of cocaine craving seen after
extended abstinence from cocaine (Conrad et al., 2008), and
disrupting trafficking of GluR2-containing AMPA receptors in
either the NAc core or shell attenuates the capacity of cocaine
to reinstate extinguished drug-seeking behavior (Famous et al.,
2008). Enhanced AMPA receptor-mediated transmission appears
to be particularly relevant to drug-seeking. Thus, intra-NAc core
administration of an AMPA receptor agonist promotes while an
antagonist inhibits cocaine-seeking (Cornish and Kalivas, 2000)
and similar results are found for both heroin (Lalumiere and
Kalivas, 2008) and alcohol (Backstrom andHyytia, 2004). Indeed,
increased AMPA-mediated transmission is consistent with a crit-
ical role for prefrontal glutamate release NAc core in mediating
reinstatement of drug-seeking behavior (McFarland et al., 2003;
Kalivas et al., 2005).
Given this established role for increased AMPA-mediated glu-
tamate in drug-seeking behavior, is potentially not surprising
that primed reinstatement of heroin-seeking in rats was recently
shown to require LTP-like increases in synaptic strength at
cortico-accumbal synapses (Shen et al., 2011). This increase in
synaptic strength was accompanied by changes in spine remod-
eling and required up-regulation of the NR2B subunit of the
NMDA receptor (Shen et al., 2011). Further studies examining
synaptic potentiation as a result of drug-seeking in the absence of
a drug prime will provide insight into the exact synaptic changes
elicited by the drug-seeking behavior itself.
By examining synaptic changes in the context of models
of chronic self-administration and drug-seeking behavior fol-
lowing extinction or abstinence, it is more likely that exper-
imental outcomes will reflect the changes occurring in the
brains of drug addicts as opposed to the being the result of
drug exposure alone. Nevertheless, while it is apparent that
drug self-administration induces long-lasting changes in synap-
tic transmission, it is unknown whether these are non-specific
adaptations that occur in all individuals exposed to drugs, or
whether these changes occur specifically in individuals devel-
oping addiction. Pioneering work from the Piazza laboratory
addressed this question by comparing synaptic transmission in
the NAc of rats that had been classified as either “addict” or “non-
addict” using DSM-IV criteria (Kasanetz et al., 2010). Cocaine
self-administering rats were classified as “addicts” if they exhib-
ited difficulty in limiting cocaine intake, increased motivation to
seek the cocaine and continued use despite adverse consequences.
It was found that after 17 days of cocaine self-administration,
both “addict” and “non-addict” rats exhibited suppression of
NMDA receptor-dependent LTD in the NAc. After 50 days of
cocaine self-administration, NMDA receptor-dependent LTDwas
restored in “non-addict” rats, but these impairments persisted in
the “addict” rats, despite no difference in the amount of cocaine
these two groups were exposed to Kasanetz et al. (2010). These
experiments provide compelling evidence that the transition to
addiction may be associated with a form of “anaplasticity,” or
an inability to counteract drug-induced impairments in synaptic
plasticity.
It is apparent from the evidence reviewed above that exposure
to drugs of abuse can induce long-lasting changes in synap-
tic strength in brain regions and circuits associated with drug
reward (Hyman et al., 2006; Kauer and Malenka, 2007; Kalivas
and O’Brien, 2008; Luscher and Malenka, 2011). In addition
to the VTA and NAc, synaptic adaptations upon exposure to
drugs have also been characterized in other components of
the mesolimbic system including the PFC, bed nucleus of the
stria terminalis and central amygdala (Dumont et al., 2005;
Fu et al., 2007; Van Den Oever et al., 2008). However, given
the above findings it appears that specific deficits in cortico-
accumbal synapses of MSNs are the most relevant to addiction
in humans.
TRANSCRIPTIONAL MECHANISMS OF DRUG-INDUCED
PLASTICITY
While it is clear that drugs of abuse are able to modify synaptic
transmission in the mesocorticolimbic system, for stable alter-
ations in neuronal functioning to be achieved, de novo protein
synthesis is required (Kandel, 2001). Indeed, repeated drug expo-
sure results in region-specific alterations in gene expression and
it has been postulated that these changes may underlie some of
the enduring behavioral abnormalities that characterize addic-
tion (McClung and Nestler, 2003; Chao and Nestler, 2004). There
are a number of mechanisms by which drugs of abuse are able
to regulate gene expression, including activation and suppression
of transcription factors, epigenetic mechanisms and induction of
non-coding RNAs.
TRANSCRIPTION FACTORS
Transcription factors are proteins that bind to specific DNA
sequences to regulate gene transcription by interacting with
the RNA polymerase II complex (Mitchell and Tjian, 1989).
Transcription factors can be induced or repressed in response
to environmental stimuli, resulting in changes in gene expres-
sion and ultimately neuronal function. A number of transcription
factors have been identified for their potential role in addic-
tion because their expression and activation is regulated in the
mesocorticolimbic pathway upon exposure to drugs of abuse.
FosB is one such transcription factor that has received partic-
ular attention due to its unusual stability. FosB is a truncated
splice variant of the FosB gene, and it shares homology with
other Fos family members including c-Fos, FosB, Fra1, and Fra2
which all heterodimerise with Jun family proteins (c-Jun, JunB,
or JunD) to form activator protein-1 (AP-1) transcription fac-
tors (Morgan andCurran, 1995). These other Fos familymembers
are induced rapidly in the striatum in response to acute admin-
istration of psychostimulants, however due to their instability
this expression is transient and returns to basal levels within
hours (Graybiel et al., 1990; Young et al., 1991; Hope et al.,
1992). Conversely, FosB accumulates in the striatum follow-
ing chronic drug administration, and its expression persists for
several weeks after the last drug exposure (Hope et al., 1994;
Nye et al., 1995; Nye and Nestler, 1996; Pich et al., 1997; Muller
and Unterwald, 2005; McDaid et al., 2006). Data from behav-
ioral experiments support a role forFosB in some of the lasting
effects imparted by drugs of abuse. Over-expression of FosB
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in the striatum results in increased locomotor responses to both
acute and chronic cocaine, and increases the reinforcing proper-
ties of both cocaine and morphine (Kelz et al., 1999; Colby et al.,
2003; Zachariou et al., 2006), whereas inhibition of FosB pro-
duces the opposite behavioral effects (Peakman et al., 2003). Due
to its ability to increase the incentive motivational properties of
drugs of abuse, this transcription factor has been proposed to
represent a “molecular switch” that facilitates the transition to
addiction (Nestler, 2008).
cAMP response element-binding protein (CREB) is another
transcription factor that has been the focus of a considerable
amount of research due to its proposed role in drug-induced
plasticity (McPherson and Lawrence, 2007). CREB is expressed
ubiquitously in the brain, and can be activated by a multitude of
intracellular signaling pathways that culminate in its phosphory-
lation at serine 133 (Mayr andMontminy, 2001). Phosphorylated
CREB (pCREB) stimulates the recruitment of CREB-binding
protein (CBP) which facilitates the transcription of various down-
stream genes (Arias et al., 1994). pCREB is rapidly induced in
the striatum upon exposure to psychostimulants (Konradi et al.,
1994; Kano et al., 1995; Walters and Blendy, 2001; Choe et al.,
2002) and this is hypothesized to represent a homeostatic mech-
anism that counteracts behavioral responses to drugs of abuse
(McClung and Nestler, 2003; Dong et al., 2006). Consistent
with this, overexpression of CREB in the NAc shell reduces the
rewarding properties of cocaine in a conditioned place prefer-
ence (CPP) paradigm, whereas the opposite is observed upon
inhibition of CREB in this region (Carlezon et al., 1998; Pliakas
et al., 2001). Similarly, genetic knockdown or inhibition of CREB
in the dorsal striatum confers increased sensitivity to the loco-
motor activating properties of psychostimulants, adding further
support to this hypothesis (Fasano et al., 2009; Madsen et al.,
2012).
While data from CPP experiments support the idea of CREB
acting as a negative modulator of drug reward, at least with
respect to cocaine, this may be an oversimplification. A num-
ber of studies using various techniques to alter CREB function
in the NAc shell have revealed that inhibition of CREB reduces
cocaine reinforcement in a self-administration paradigm (Choi
et al., 2006; Green et al., 2010; Larson et al., 2011), whereas
cocaine reinforcement is enhanced by CREB overexpression in
this region (Larson et al., 2011). These divergent findings are
probably due to fundamental differences between instrumen-
tal and Pavlovian conditioning procedures as well as voluntary
vs. involuntary drug administration. CPP involves associative
learning processes, and is thought to be an indirect measure
of the hedonic properties of a drug rather than drug rein-
forcement per se (Bardo and Bevins, 2000). Voluntary drug
self-administration can be influenced by a number of emo-
tional factors, and the ability of CREB activity in the NAc to
reduce responses to anxiogenic stimuli (Barrot et al., 2002) and
attenuate depressive behavior (Pliakas et al., 2001) could influ-
ence the propensity to self-administer drug. Interestingly, dele-
tion of CREB from the PFC results in decreased motivation to
self-administer cocaine (McPherson et al., 2010), demonstrat-
ing that the effect of CREB manipulation upon behavior also
varies for different brain regions. This is perhaps not surprising
given that the CREB transcriptome differs markedly according
to the cell type (Cha-Molstad et al., 2004) and it would there-
fore be important to identify the changes in gene expression
occurring down-stream of CREB that contribute to these phe-
notypes. Complicating things further is the observation that
CREB in the NAc shell is essential for nicotine CPP (Brunzell
et al., 2009), suggesting that the mechanisms underlying con-
ditioned nicotine reward differ from those underlying cocaine
and morphine, which are both enhanced by CREB inhibition
in the NAc shell (Carlezon et al., 1998; Pliakas et al., 2001;
Barrot et al., 2002).
EPIGENETICMECHANISMS
Epigenetics has a number of definitions, but in neuroscience it
is commonly defined as changes in gene expression that occur
through modulation of chromatin which are not brought about
by changes in the underlying DNA sequence (McQuown and
Wood, 2010). Chromatin describes the state of DNA when it
is packaged within the cell. The basic repeating unit of chro-
matin is the nucleosome, which consists of 147 base pairs of
DNA wrapped around an octamer composed of pairs of the
four core histones (H2A, H2B, H3, and H4) (Luger et al.,
1997). The amino terminal tails of these core histones can
undergo a number of post-translational modifications includ-
ing acetylation, methylation, phosphorylation, ubiquitination,
and sumoylation (Berger, 2007). The addition and removal
of these functional groups from histone tails is carried out
by a large number of histone modifying enzymes, includ-
ing acetyltransferases, deacetylases, methyltransferases, demethy-
lases, and kinases (Kouzarides, 2007). These histone modifi-
cations serve to signal the recruitment of transcription fac-
tors and other proteins involved in transcriptional regulation,
and alter chromatin conformation to make DNA more or less
accessible to the transcriptional machinery (Strahl and Allis,
2000; Kouzarides, 2007; Taverna et al., 2007). Epigenetic mech-
anisms therefore represent an important means by which envi-
ronmental stimuli can regulate gene expression and ultimately
behavior.
Recently, chromatin modification has been recognized as an
important mechanism underlying drug-induced changes in plas-
ticity and behavior (Renthal and Nestler, 2008; Bredy et al., 2010;
McQuown and Wood, 2010; Maze and Nestler, 2011; Robison
and Nestler, 2011). The first evidence for this came from exper-
iments by Kumar and colleagues who used chromatin immuno-
precipitation (ChIP) assays to demonstrate that cocaine induces
histone modifications at specific gene promoters in the stria-
tum (Kumar et al., 2005). Specifically, acute administration of
cocaine resulted in H4 hyperacetylation of the cFos promoter,
whereas chronic administration resulted in H3 hyperacetylation
of the BDNF and Cdk5 promoters. Histone acetylation involves
the enzymatic transfer of an acetyl group to a histone’s basic
N-terminal tail, which neutralises the electrostatic interaction
between the histone and the negatively charged DNA, making
it more accessible to the transcriptional apparatus (Loidl, 1994).
This is consistent with the ability of cocaine to increase the expres-
sion of Fos family transcription factors acutely (Graybiel et al.,
1990; Young et al., 1991), whereas BDNF and Cdk5 are induced
Frontiers in Molecular Neuroscience www.frontiersin.org November 2012 | Volume 5 | Article 99 | 8
Madsen et al. Neuroplasticity in addiction
only upon chronic exposure (Bibb et al., 2001; Grimm et al.,
2003).
A histone hyperacetylated state can also be achieved exper-
imentally by administration of histone deacetylase (HDAC)
inhibitors, and these drugs have been used to examine the
effects of global increases in histone acetylation upon behav-
ioral responses to drugs of abuse. Systemic administration of
HDAC inhibitors synergistically increases the hyperacetylation
observed in response to cocaine within the striatum (Kumar
et al., 2005), and this potentiates cocaine-induced locomotion
and cocaine reward (Kumar et al., 2005; Sun et al., 2008;
Sanchis-Segura et al., 2009). HDAC inhibition can also increase
locomotor sensitization to ethanol and morphine, and facili-
tate morphine CPP (Sanchis-Segura et al., 2009), Nevertheless,
HDAC inhibitors have also been found to prevent the devel-
opment of sensitization to a single morphine exposure (Jing
et al., 2011), and reduce the motivation to self-administer
cocaine (Romieu et al., 2008). These contrasting findings may
reflect differences in administration protocols, and impor-
tantly they demonstrate that HDAC inhibitors do not indis-
criminately potentiate behavioral responses to drugs in all
conditions.
Due to their permissive effect upon gene transcription, HDAC
inhibitors may also act to facilitate certain types of learning
(Bredy et al., 2007; Lattal et al., 2007). It has recently been
demonstrated that administration of a HDAC inhibitor follow-
ing re-exposure to a previously cocaine-paired environment can
facilitate extinction of cocaine-induced CPP, and this is probably
related to increased histone H3 acetylation in the NAc (Malvaez
et al., 2010). Infusion of the HDAC inhibitor suberoylanilide
hydroxamic acid (SAHA) directly into the NAc during the con-
ditioning phase of CPP increases conditioned cocaine reward
(Renthal et al., 2007), indicating that HDAC inhibition in this
region can facilitate both reward-related learning and extinc-
tion learning, depending upon the context in which the drug
is administered. Further experiments have revealed a role for
HDAC5, and endogenous HDAC expressed highly in the NAc in
modulation of cocaine reward. Cocaine administration increases
HDAC5 function by regulating its dephosphorylation and sub-
sequent nuclear import, and dephosphorylation of HDAC5 in
the NAc impairs the development of a cocaine CPP (Taniguchi
et al., 2012). Similarly, over-expression of HDAC5 in the NAc
during the conditioning phase of CPP attenuates cocaine reward,
and this effect is reversed upon expression of a mutant form
of HDAC5 in the NAc (Renthal et al., 2007). It is possible that
HDAC5 is exerting these effects by inhibiting drug-induced gene
transcription that normally increases the rewarding properties
of cocaine.
Genome-wide analysis of chromatin modifications that occur
in the NAc as a result of cocaine exposure has revealed a
multitude of chromatin modifications at the promoter regions
of genes down-stream of both CREB and FosB (Renthal
et al., 2009). This analysis also revealed up-regulation of two
sirtuins, SIRT1 and SIRT2, which are proteins that possess
HDAC activity and can also deacetylate other cellular pro-
teins (Denu, 2005). Induction of SIRT1 and SIRT2 is associ-
ated with increased H3 acetylation and increased binding of
FosB at their gene promoters, suggesting that they are down-
stream targets ofFosB (Renthal et al., 2009). The up-regulation
of SIRT1 and SIRT2 is thought to have behavioral relevance;
sirtuins decrease the excitability of NAc MSNs in vitro, and
pharmacological inhibition of sirtuins decreases cocaine reward,
whereas their activation increases rewarding responses to cocaine
(Renthal et al., 2009).
In addition to the functional role for HDACs, genetic stud-
ies have also revealed a role for histone acetyltransferases
(HATs) in mediating some of the behavioral responses to
drugs of abuse. Arguably the most important mechanism by
which CBP is able to enhance gene transcription is via its
intrinsic HAT activity (Bannister and Kouzarides, 1996), and
recent findings implicate the HAT activity of CBP in some
of the epigenetic changes that result from drug exposure. In
response to acute cocaine, CBP is recruited to the FosB pro-
moter where it acetylates histone H4 and increases expres-
sion of FosB (Levine et al., 2005). In mice haploinsufficient
for CBP, less CBP is recruited to the promoter resulting in
decreased histone acetylation and FosB expression. This also
corresponds to less accumulation of FosB in the striatum,
and not surprisingly these mice exhibit decreased sensitiza-
tion in response to a cocaine challenge (Levine et al., 2005).
Recently, using the cre-lox recombination system Malvaez and
colleagues investigated the role of CBP activity located specifi-
cally in the NAc upon cocaine-induced gene transcription and
behavior (Malvaez et al., 2011). It was reported that targeted
deletion of CBP in the NAc resulted in reduced histone acety-
lation and c-Fos expression, and impaired locomotor activation
in response to both acute and chronic cocaine (Malvaez et al.,
2011). Conditioned cocaine reward was also inhibited in these
mice, providing the first evidence that CBP activity in the NAc
is important for the formation of drug-associated memories
(Malvaez et al., 2011).
Recently, experiments from the Kandel lab have revealed
that epigenetic mechanisms may underlie nicotine’s hypothesized
ability to act as a “gateway drug”. Mice chronically pretreated
with nicotine prior to cocaine exposure exhibited enhanced loco-
motor sensitization and cocaine reward compared to nicotine
naive mice (Levine et al., 2011). Additionally, nicotine pre-
treatment resulted in enhanced cocaine-induced depression of
LTP in excitatory synapses in the NAc core, an effect that was
not seen with nicotine alone. Analysis of histone modifications
induced by 7-day nicotine exposure revealed increased H3 and
H4 acetylation at the FosB promoter in the striatum, an effect
that was not as pronounced in response to 7-day cocaine admin-
istration. HDAC activity was reduced in the striatum of nico-
tine treated mice, but unchanged in mice treated with cocaine.
Remarkably, infusion of a HDAC inhibitor directly into the NAc
was able to mimic the effects of nicotine pretreatment in poten-
tiating cocaine’s effects. None of these changes were observed
when mice were treated with cocaine prior to nicotine, con-
firming the temporal specificity of these effects. This elegant
set of experiments has provided a possible epigenetic explana-
tion as to why cigarette smoking almost always precedes cocaine
use in the human population (Kandel, 1975; Kandel et al.,
1992).
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In addition to histone acetylation, histone methylation has
also recently been recognized as a behaviorally relevant chro-
matin modification induced by drugs of abuse (Laplant et al.,
2010; Maze et al., 2010, 2011). Histone methylation involves
the enzymatic addition of one, two, or three methyl groups to
lysine or arginine residues at the N-terminal of histone tails,
and is associated with either transcriptional activation or repres-
sion, depending upon the nature of the modification (Rice and
Allis, 2001). The first studies to examine histone methylation
induced by cocaine led to the identification of two histone
methyltransferases, G9a and G9a-like protein (GLP), that were
persistently down-regulated in the NAc 24 h following both non-
contingent cocaine exposure and cocaine self-administration
(Renthal et al., 2009; Maze et al., 2010). This down-regulation
was linked to similar decreases in histone H3 lysine 9 (H3K9)
and 27 (H3K27) methylation. Subsequently, G9a overexpression
in the NAc was demonstrated to reduce cocaine-induced expres-
sion of selected genes, decrease cocaine reward as measured by
CPP, and inhibit the increases in dendritic spine density nor-
mally observed in response to repeated cocaine (Maze et al.,
2010). The opposite occurred when G9a expression in the NAc
was inhibited, resulting in increased dendritic spine density and
enhanced cocaine reward. There is evidence that these cocaine-
induced changes in G9a expression and subsequent decreases
in H3K9 and H3K27 are regulated by FosB (Maze et al.,
2010). Collectively, these experiments identified an important
role for histone methylation by G9a in some of the long term
behavioral and biochemical consequences of repeated exposure
to cocaine.
Recently, trimethylation of histone H3 lysine 9 (H3K9me3)
which was previously thought to be a relatively stable hete-
rochromatic mark, was shown to be dynamically regulated in
the NAc by acute and chronic cocaine exposure (Maze et al.,
2011). Repeated cocaine resulted in persistent decreases in
repressive H3K9me3 binding which was particularly enriched
in non-coding genomic regions (Maze et al., 2011). These ini-
tial findings suggest that repeated cocaine exposure may lead
to the unsilencing of certain retrotransposable elements in
NAc neurons, and it would be of great interest to ascertain
the behavioral consequences of these novel epigenetic adapta-
tions.
Given the enduring nature of addiction, recent research
has also explored the role of DNA methylation, which is a
more stable epigenetic adaptation compared to histone mod-
ification. DNA methylation involves the addition of methyl
groups to cysteine bases in DNA, and it is generally associ-
ated with transcriptional repression (Stolzenberg et al., 2011).
Analysis of brains of rats that received passive cocaine injec-
tions over 7 days, or that self-administered cocaine over 13
days revealed down-regulation of the DNA methyltransferase
DNMT3a in the NAc 24 h after the last cocaine exposure
(Laplant et al., 2010). Conversely, following more chronic cocaine
exposure (both passive and self-administered for 3 weeks or
more) and a 28 day withdrawal period, dnmt3a mRNA was
found to be significantly enhanced in the NAc (Laplant et al.,
2010). Inhibition of DNA methylation/DNMT3a specifically in
the NAc was subsequently shown to enhance both CPP and
locomotor sensitization to cocaine, whereas the opposite was
observed following overexpression of DNMT3a in this region.
Moreover, inhibition of DNMT3a in the NAc also prevented
cocaine-induced increases in dendritic spine density (Laplant
et al., 2010). The behavioral relevance of cocaine-induced
alterations in NAc spine density is still not well understood.
Manipulations that inhibit drug-induced spine induction have
been shown to reduce the rewarding properties of cocaine
(Russo et al., 2009; Maze et al., 2010); however, other studies
have found that inhibition of spinogenesis potentiates cocaine
reward (Pulipparacharuvil et al., 2008; Laplant et al., 2010). As
cocaine appears to induce a highly complex regulation of vari-
ous dendritic spines over the course of exposure and withdrawal
(Shen et al., 2009), it has been suggested that these differences
may depend upon the type of dendritic spines that are altered
(Laplant et al., 2010).
From the experiments described herein, it is clear that drug-
induced regulation of the transcriptional potential of cells rep-
resents a key mechanism influencing behavioral responses to
drugs and reward-related learning. An important next step
would be to identify which of these epigenetic changes are
most relevant to the human disease state of addiction. Given
that mere exposure to drugs is insufficient to produce “addic-
tion” in both humans and animals, the incorporation of models
that more closely measure behavioral hallmarks of addiction,
such as compulsive drug use and relapse will be of significant
value.
MicroRNAs
MicroRNAs represent yet another important means by which
drugs of abuse can regulate gene expression. MicroRNAs are
small, non-coding RNA transcripts that act to inhibit gene
translation at the post-transcriptional level by targeting the 3′-
untranslated region (3′UTR) (Bartel, 2004). Recent work by Paul
Kenny’s group has lead to the identification of transcriptional
regulation by microRNAs that occurs specifically in rats with
extended access to cocaine self-administration (Hollander et al.,
2010; Im et al., 2010). Extended access models precipitate esca-
lating, compulsive patterns of drug-intake which is thought to
be reminiscent of the uncontrolled drug use that characterizes
human addiction (Ahmed and Koob, 1998; Deroche-Gamonet
et al., 2004; Vanderschuren and Everitt, 2004). In rats with
a history of extended access to cocaine, the microRNA miR-
212 was up-regulated in the dorsal striatum (Hollander et al.,
2010), a brain region that becomes progressively engaged with
prolonged drug experience (Letchworth et al., 2001; Porrino
et al., 2004). Virally-mediated over-expression of miR-212 in the
dorsal striatum decreased the motivation to consume cocaine,
but only under extended access conditions (Hollander et al.,
2010). Inhibition of miR-212 signaling in this region pro-
duced the opposite effect, and facilitated compulsive cocaine
self-administration. miR-212 is induced in response to CREB
signaling (Vo et al., 2005), and exerts its effects by potentiat-
ing the activity of CREB (Hollander et al., 2010), revealing a
novel feedforward mechanism whereby miR-212 is seemingly
able to protect against the development of compulsive cocaine
intake.
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Expression of the transcription factor MeCP2 is also specifi-
cally increased in the dorsal striatum of rats following extended
access to cocaine (Im et al., 2010). Disruption of MeCP2 activity
in the dorsal striatum prevents the escalation of drug intake nor-
mally seen in extended access rats, and results in a progressive
decline in responding for cocaine. Unlike CREB and FosB,
MeCP2 is a transcriptional repressor, exerting its effects by
recruiting HDACs and other transcriptional repressors to silence
target genes (Nan et al., 1998). MeCP2 acts to repress expres-
sion of miR-212 in the dorsal striatum in an activity dependent
manner, and also controls the expression of brain-derived neu-
rotrophic factor (BDNF), a protein with an established role
in modulating cocaine-related behaviors (Horger et al., 1999;
Graham et al., 2007). miR-212 can also feedback to repress expres-
sion of MeCP2, and these two transcriptional regulators are
involved in a negative homeostatic balancing act (Im et al., 2010).
These studies highlight the complexity of transcriptional reg-
ulation that occurs as a result of drug self-administration, and
suggest that voluntary drug intake is controlled by a fine bal-
ance of opposing molecular regulators that act to facilitate or
inhibit compulsive drug use. It would be of great interest to ascer-
tain whether transcriptional regulation by miR-212/MeCP2 is
involved in the mechanism of “recovery” observed in non-addict
rats (Kasanetz et al., 2010), and this may bring us closer to under-
standing factors that underlie both vulnerability and resilience to
addiction (Ahmed, 2012).
CONCLUSIONS
Research over the last decade has provided insight into the abil-
ity of drugs of abuse to modify synaptic transmission within
mesocorticolimbic and corticostriatal circuitry, and we are now
beginning to unravel the behavioral significance of some of these
changes. More recently, the growing field of epigenetics has shed
light upon some of themechanisms by which drugs of abuse regu-
late the transcriptional potential of cells, to initiate lasting changes
in gene expression. This research has opened up several poten-
tial therapeutic avenues. The discovery that N-acetylcysteine is
able to restore synaptic deficits induced by self-administration
of cocaine, and inhibits reinstatement of drug-seeking offers
promise for “rehabilitated” addicts (Moussawi et al., 2011).
HDAC inhibitors are gaining attention for their ability to enhance
certain types of learning, and the recent discovery that sodium
butyrate can facilitate extinction of a cocaine-induced CPP and
attenuate reinstatement of drug-seeking is promising (Malvaez
et al., 2010). An important next step would be to interrogate the
ability of HDAC inhibitors to facilitate extinction of operant self-
administration, which more accurately models voluntary drug
consumption in humans. Finally, the identification of factors that
regulate escalating drug use both on a synaptic level (e.g., persis-
tent impairments in NMDAR-dependent LTD in the NAc) and
on a molecular level (e.g., striatal signaling pathways involving
miR-212 andMeCP2) are bringing us closer to understanding the
mechanisms that underpin the transition to addiction (Hollander
et al., 2010; Im et al., 2010; Kasanetz et al., 2010). These studies
highlight the importance of examining neuroplastic changes that
are brought about by voluntary drug self-administration rather
than passive drug exposure. Moving forward it would be impor-
tant for more research to incorporate these self-administration
models that more closely mimic the behavioral pathology seen
in human addicts.
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